Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Autism Adult Stem Cell Gene-modified, donor cell therapy UC Davis
Development Candidate, Proof of Concept
Heart Disease,
Vascular Disease
iPS Cell Small molecule therapy Gladstone
Development Candidate
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy CIT
Proof of Concept
Cystinosis Adult Stem Cell Gene-modified, personalized cell therapy UCSD
IND
Heart disease associated with Duchenne muscular dystrophy Adult Stem Cell Donor cell therapy Capricor
Clinical Trial, Phase 2
Kidney Failure Adult Stem Cell Biologic Humacyte
Clinical Trial, Phase 3
Osteonecrosis Adult Stem Cell Personalized cell therapy Ankasa
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Embryonic Stem Cell Donor cell therapy USC
Pre-IND/IDE or Equivalent
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy CHORI
Pre-IND/IDE or Equivalent
Pulmonary Hypertension,
Vascular Disease
Adult Stem Cell Donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Colon Cancer Cancer Stem Cell Antibody Forty Seven
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Type 1 diabetes Embryonic Stem Cell Device UCSF
Proof of Concept
Liver Disease Adult Stem Cell Donor cell therapy Stanford
Development Candidate
Huntington's Disease Embryonic Stem Cell Gene-modified, donor cell therapy UC Irvine
Development Candidate, Proof of Concept
Heart Disease Directly Reprogrammed Cell Gene modification Gladstone
Proof of Concept
Parkinson's Disease iPS Cell Gene modification Parkinson's Institute
Development Candidate, Proof of Concept
Blood Cancer,
Ovarian Cancer
iPS Cell Donor cell therapy UCSD
Development Candidate
Blood Disorders,
Blood Cancer
Adult Stem Cell Small molecule therapy UCLA
Development Candidate
Diabetes Embryonic Stem Cell Donor cell therapy UCSF
Development Candidate, Proof of Concept
Cystic Fibrosis Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Neurological Disorders,
Zika virus
iPS Cell Small molecule therapy UCSD
Development Candidate
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
IND
Retinitis Pigmentosa Adult Stem Cell Donor cell therapy jCyte
Clinical Trial, Phase 2
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Vascular Disease Adult Stem Cell Biologic UCSD
Pre-IND/IDE or Equivalent
Heart Disease iPS Cell Assay development Stanford
Tool/Resources/Bottleneck
Type 1 diabetes Adult Stem Cell Personalized cell therapy Caladrius Biosciences
Clinical Trial, Phase 2
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Vision Loss Embryonic Stem Cell Donor cell therapy USC
Proof of Concept, Research Insights
Heart Disease iPS Cell Donor cell therapy UCSF
Proof of Concept
Muscular Dystrophy Embryonic Stem Cell,
iPS Cell
Specific Cell Type Derivation Sanford-Burnham
Research Insights
Skeletal/Smooth Muscle disorders Adult Stem Cell Protein/peptide therapy Stanford
Research Insights
B cell cancers,
Leukemia
Cancer Stem Cell Antibody COH
Development Candidate, Proof of Concept
Parkinson's Disease iPS Cell Cell processing & handling Scaled Biolabs Inc.
Development Candidate
Liver Disease Directly Reprogrammed Cell Gene modification UCSF
Development Candidate
Heart Disease iPS Cell Model system development UC Berkeley
Proof of Concept
Colon Cancer Cancer Stem Cell Small molecule therapy COH
Development Candidate, Proof of Concept
Heart Disease iPS Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Heart Disease iPS Cell Personalized cell therapy UC Davis
Proof of Concept
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Other Embryonic Stem Cell,
iPS Cell
Cell processing & handling X-Therma
Proof of Concept, Tool/Resources/Bottleneck
Cancer Embryonic Stem Cell Donor cell therapy UCLA
Tool/Resources/Bottleneck
Huntington's Disease Embryonic Stem Cell Small molecule therapy Rumi Scientific CA
Development Candidate
Neurological Disorders,
Zika virus
Adult Stem Cell,
iPS Cell
Vaccine UCLA
Development Candidate
Traumatic Brain Injury Embryonic Stem Cell Donor cell therapy UC Irvine
Development Candidate
Stroke Embryonic Stem Cell Donor cell therapy Stanford
IND
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody Cellerant Therapeutics, Inc.
IND
Stroke Adult Stem Cell Gene-modified, donor cell therapy SanBio, Inc.
Clinical Trial, Phase 2

Pages

Icon for csv export